LONG TERM FOLLOW-UP
Long term follow-up begins when the protocol treatment is discontinued, treatment toxicities have resolved, and the response to therapy has been determined. The purpose of long term follow-up is to assure continued medical surveillance and allow meaningful end-results reporting. Study endpoints are dependent on having meaningful data on items such as recurrence, disease status, survival, long term adverse events or new malignancies.
It is the responsibility of the clinical research professional to design and coordinate an effective patient follow-up system. Database or spreadsheet computer programs are helpful in managing long term follow-up as data can be sorted by a number of different parameters such as last contact date, patient name, or physician to contact for follow-up information. Smaller sites can use a simple card file reminder system.
Most SWOG studies require follow-up data to be submitted every six months for the first two years then annually thereafter unless more stringently specified in the protocol. The Data Submission Schedule (Section 14 in the protocol) provides information on the frequency of data submission, the length of time follow-up data is required, and the forms to be used on the study. Some studies require many years of follow-up while some phase II studies may require follow-up for just a few years.
The CRA Workbench on the SWOG Web site (www.swog.org) offers useful reports, forms and tools to facilitate follow-up. The Expectation Report provides the date of last contact. The Followup, Notice of Death, and Off Treatment Notice forms are completed and submitted electronically via the CRA Workbench or Medidata Rave.
The Off Treatment Notice form is submitted when protocol treatment is discontinued. The Follow Up Form is utilized to submit follow-up data once protocol treatment is complete. If a patient completed protocol treatment without progressive disease, the CRA should submit a Follow Up Form upon learning that the patient has relapsed, recurred, or has progressive disease. The Follow Up Form is used to indicate a patient has a new primary or a long-term adverse event. Some protocols may have protocol specific forms related to progression of disease and followup. Always refer to the Study Calendar and Data Submission section of the protocol to determine the appropriate forms required for the study.
Responsibility for Patient Follow-up
SWOG Policy Memorandum No. 30 defines responsibility for patient follow-up, procedures for transferring a patient to another institution, the criteria utilized to classify a patient as "lost to followup," and things to discuss with the patient if they wish to withdraw consent. It is important you be familiar with and use the most current policy to assure compliance with procedures and required documentation.
The following policies will be observed by all Group members in regard to follow-up of patients registered to studies coordinated by SWOG: Sources of Information for Follow-up A number of sources may be utilized to obtain follow-up data. Always check the hospital or physician office record first. Referring physicians may be able to provide information or an updated address or telephone number. Some physicians may require a copy of the study consent to release information and some may not provide data at all. Some facilities may require an authorization for release of health information. The patient may be contacted directly if your facility policies permit it. If you utilize relatives and other non-hospital sources to locate the patient, extreme care must be taken not to violate patient confidentiality policies.
1.
In-hospital sources; a.
Medical record/Hospital information system; b.
Readmissions; c.
Clinics; d.
Outpatient departments; e.
Radiation therapy department. 2.
Current physicians. (Sample letter on page 8) 3.
Referring physicians. 4.
Hospital cancer registries. 5.
Direct contact with patient. 6.
Relative or other follow-up contact. 7.
State population-based cancer registries or other central cancer registries. 8.
Home health agencies. 9.
Current telephone directories for entire state. 10.
City/county directory, cross-referenced by resident name and address (a copy may be in a hospital business office or development office, or in the library. Borrow these annual publications, as the costs are very high. 11.
County welfare department. 12.
Vital statistics office (local, county, state). 13.
Religious affiliation. 14.
Present or former employer, (use caution; discrimination may cause a patient to lose his job 
Strategies to Use in Long Term Follow-up
Communication with your patient during the informed consent process, treatment, and after treatment is completed is extremely important in maintaining up to date follow-up. Develop a good relationship with your patients. Let patients know you will be contacting them on a periodic basis. Proactive efforts when a patient is placed on a study will facilitate the collection of long term followup data. You may obtain additional contact information for a patient to include other persons who generally know the whereabouts of the patient. This may include names, telephone numbers, addresses, and email addresses. A sample Research Participant Contact Information form is included on page 9. The form can be completed at the time the consent document is reviewed and updated during visits and follow-up contacts. Review this information with the patient/participant on an annual basis.
Maintain old addresses, telephone numbers, or other contact information. It may be helpful to go back to previous contacts. Document follow-up attempts in a notes section of your research record.
Appointment reminders are helpful, especially for prevention studies. When permitted, send birthday cards or other greeting cards to patients and participants.
Provide postage paid envelopes if you are asking for something to be returned. These may be printed or simply add a stamp to the return envelope. This is often helpful for patients and physician offices and helps assure the form is returned to the correct mailing address.
Utilize caution when using email or other social media to contact patients. Email is typically not a secure method for transmitting confidential information. Check your institutional or organizational policies for contacting patients and accessing information via social media sites to obtain followup information.
Patient Transfers
A patient transfer is initiated if a patient goes to another SWOG institution for treatment or followup, ex., a patient moves. To initiate a patient transfer, you must go to the CRA Workbench and select "Patient Transfer." Both the transferring and the accepting investigators must approve the transfer. Current IRB approval is required at the new institution. We are seeking information on one of our patients, ____________________________. This patient participated in one of our SWOG studies and we are in need of information pertaining to survival status. We would very much appreciate it if you will provide us with the following information at your earliest convenience. A postage paid envelope is enclosed for your convenience. CONTACT #1 CONTACT #2 CONTACT #3 NAME : NAME : NAME : 
